DR. MARTIN STUART ZAND, MD, PHD
Osteopathic Medicine at Elmwood Ave, Rochester, NY

License number
New York 209991
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
601 Elmwood Ave, Rochester, NY 14642
Phone
(585) 275-4517
(585) 442-9201 (Fax)
(585) 275-7753
National Provider ID: 1326020249
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about MARTIN STUART ZAND at radaris.com
Name
Address
Phone
Martin Zand
129 Westland Ave, Rochester, NY 14618
Martin Zand
129 Westland Ave, Rochester, NY 14618
Martin Zand
149 Westland Ave, Rochester, NY 14618

Professional information

Martin Zand Photo 1

Professor Of Medicine At University Of Rochester Medical Center
Position:
Director: University of Rochester Center for Biodefense Immune Modeling at University of Rochester Medical Center, Professor of Medicine at University of Rochester Medical Center, Medical Director, Kidney and Pancreas Transplant Programs at University of Rochester Medical Center
Location:
Rochester, New York Area
Industry:
Hospital & Health Care
Work:
University of Rochester Medical Center since 2005 - Director: University of Rochester Center for Biodefense Immune Modeling University of Rochester Medical Center since 1998 - Professor of Medicine University of Rochester Medical Center since 1998 - Medical Director, Kidney and Pancreas Transplant Programs Harvard Medical School 1996 - 1998 - Post-Doctoral Fellow in Immunology Beth Israel Deaconess Medical Center 1995 - 1998 - Fellow in Nephrology
Education:
Northwestern Univeristy 1985 - 1992
MD, Medicine Northwestern University 1986 - 1990
PhD, Cell, Molecular, and Structural Biology Northwestern University 1981 - 1985
B.S.E., Biomedical Engineering
Languages:
Spanish
Certifications:
Board Certified, Nephrology, American Board of Internal Medicine
Board Certified, Internal Medicine, American Board of Internal Medicine

Martin S Zand Photo 2

Dr. Martin S Zand - MD (Doctor of Medicine)
Hospitals:
Strong Renal Group
601 Elmwood Ave SUITE 675, Rochester 14642
601 Elmwood Ave, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Strong Renal Group
601 Elmwood Ave SUITE 675, Rochester 14642
601 Elmwood Ave, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Education:
Medical Schools
Northwestern University The Feinberg School Of Medicine
Graduated: 1992

Martin S Zand Photo 3

Martin S Zand, Rochester NY
Specialties:
Internal Medicine, Nephrology, Pediatrics
Work:
Strong Memorial Hospital
 601 Elmwood Ave, Rochester, NY 14642
Education:
Northwestern University (1992)

Martin Zand Photo 4

Analyte-Releasing Beads And Use Thereof In Quantitative Elispot Or Fluorispot Assay

US Patent:
2010029, Nov 25, 2010
Filed:
Apr 30, 2007
Appl. No.:
12/298626
Inventors:
Martin S. Zand - Rochester NY, US
Alicia D. Henn - Rochester NY, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
C12Q 1/70, C12Q 1/68, G01N 33/53
US Classification:
435 5, 435 6, 435 71, 435 79
Abstract:
The present invention relates to a method of quantifying analyte secreted by a cell or released from a drug delivery vehicle, typically by ELISpot or fluorispot assay. Quantification is possible through the use of an analyte-releasing reagent that includes a bead and the analyte releasably bound to the bead, or a container pre-spotted with analyte released from the reagent. The reagent or pre-spotted containers can be used to provide a standard curve for release of the analyte. By detecting analyte secreted by one or more cells or drug released by a drug delivery vehicle, and comparing the detected analyte to the standard curve, it is possible to quantify the amount of analyte released by the one or more cells or drug released by the drug delivery vehicle. Kits and reagents for practicing the methods of the present invention are also disclosed.

Martin Zand Photo 5

Anti-Thymocyte Antiserum And Use Thereof To Trigger B Cell Apoptosis

US Patent:
2007003, Feb 8, 2007
Filed:
Oct 22, 2004
Appl. No.:
10/576428
Inventors:
Martin Zand - Rochester NY, US
Jainulabdeen Ifthikharuddin - Rochester NY, US
Jane Liesveld - Rochester NY, US
Camille Abboud - Rochester NY, US
International Classification:
A61K 39/395
US Classification:
424144100, 424155100
Abstract:
Methods and products are described for inducing B cell apoptosis, using antibody-induced apoptosis. Specifically, polyclonal antiserum or one or more monoclonal antibodies, either alone or in combination, as well as fragments or variants thereof are employed in the methods and products of the present invention. These antibodies, or fragments or variants thereof, are capable of binding to B cell surface markers under conditions effective to collectively or individually induce apoptosis of the contacted B cell. Consequently, the methods and products of the present invention can be used therapeutically to treat, or as a preventative agent to protect against, a B cell-related condition or disorder.

Osteopathic Medicine licenses in New York










Other Doctors licenses in New York